Corrigendum to “Three months extended-release microspheres prepared by multi-microchannel microfluidics in beagle dog models” [Int. J. Pharm. 608 (2021) 121039](S0378517321008450)(10.1016/j.ijpharm.2021.121039)

  • Ju Hee Kim
  • , Choong Ho Ryu
  • , Chan Hee Chon
  • , Seyeon Kim
  • , Sangno Lee
  • , Ravi Maharjan
  • , Nam Ah Kim
  • , Seong Hoon Jeong

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the following text must be corrected since Fig. 3c, 3d, 4, 5d, and 5e were processed from the same raw data for one-month dog PK study published in the earlier article (https://doi.org/10.1016/j.ijpharm.2021.120527). The authors would like to apologise for any inconvenience caused. The corrected legends for Figs. 3, 4, and 5 are as below with the reference: Fig. 3. (a) Plasma drug concentration–time profiles after the administration of microspheres based on the ratio of 7502A:API (4:1) and 5002A:API (4:1), (b) cumulative plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1) and 5002A:API (4:1), (c) plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1), 7502A:API (2:1), and 7502A:API (2:1) with 20 mg API (71.4% of dose) (black line), and (d) cumulative plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1), 7502A:API (2:1), and 7502A:API (2:1) with 20 mg API (71.4% of dose) (black line). Each point represents the mean ± SD (n = 9). Red and blue lines in (c) and (d) were generated using the same raw data reported earlier (Kang et al., 2021). Fig. 4. (a) Plasma drug concentration–time profiles after the administration of microspheres based on 2.8 mg drug (10% of dose), 5.6 mg drug (20% of dose), 11.2 mg drug (40% of dose), 16.8 mg drug (60% of dose), and 28 mg drug (100% of dose), and (b) cumulative plasma drug concentration–time profiles after the administration of the microspheres. Each point represents the mean ± SD (n = 5). Results were generated using the same raw data reported earlier (Kang et al., 2021). Fig. 5. (d) Plasma concentration of 1 mg Propecia® tablet, and (e) 1 month simulation study of the plasma concentration of the drug-loaded microspheres injectable. Each point represents the mean ± SD (n = 5). (d) and (e) were generated using the same raw data reported earlier (Kang et al., 2021).

Original languageEnglish
Article number121267
JournalInternational Journal of Pharmaceutics
Volume611
DOIs
StatePublished - 5 Jan 2022

Fingerprint

Dive into the research topics of 'Corrigendum to “Three months extended-release microspheres prepared by multi-microchannel microfluidics in beagle dog models” [Int. J. Pharm. 608 (2021) 121039](S0378517321008450)(10.1016/j.ijpharm.2021.121039)'. Together they form a unique fingerprint.

Cite this